title: Antierythropoietin antibody-induced pure red cell aplasia: posttransplant evolution.
abstract: Pure red cell aplasia is a rare complication of recombinant human erythropoietin (rHuEPO) treatment, which physicians should consider once the more frequent causes of hyporegenerative anemia have been excluded. To our knowledge, no pediatric cases have been described. In our patient, cyclosporin A treatment enabled a reduction in the number of transfusions and the risk of hyperimmunization. After transplantation, our patient's hemoglobin level has remained normal and stable.
authors.affiliation: Pediatric Nephrology Unit, Hospital "La Paz", Madrid, Spain.
authors.forename: Angel
authors.initials: A
authors.lastname: Alonso Melgar
authors.forename: Marta
authors.initials: M
authors.lastname: Melgosa Hijosa
authors.forename: Rafael
authors.initials: R
authors.lastname: Pardo de la Vega
authors.forename: Carmen
authors.initials: C
authors.lastname: García Meseguer
authors.forename: Mercedes
authors.initials: M
authors.lastname: Navarro Torres
mesh_terms: D000293:Adolescent; D000906:Antibodies / Q000276:immunology*; D004921:Erythropoietin / Q000009:adverse effects* / Q000276:immunology*; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D011994:Recombinant Proteins; D012010:Red-Cell Aplasia, Pure / Q000276:immunology* / Q000601:surgery
chemical_list: D000906:Antibodies; D011994:Recombinant Proteins; D004921:Erythropoietin